Rajesh N. Kalaria

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Astrocyte-driven small vessel disease is an early, amyloid-independent feature of PSEN1 E280A familial Alzheimer's disease.

Astrocyte-driven small vessel disease is an early, amyloid-independent feature of PSEN1 E280A familial Alzheimer's disease.

Journal: bioRxiv : the preprint server for biology

Published: August 01, 2026

VasCog-2-WSO Criteria for Vascular Cognitive Impairment and Dementia: A Revised Standard Put to the Test.

VasCog-2-WSO Criteria for Vascular Cognitive Impairment and Dementia: A Revised Standard Put to the Test.

Journal: Neurology

Published: July 30, 2026

Global burden of cerebral small vessel disease determined from large MRI studies: A systematic review and meta-analysis.

Global burden of cerebral small vessel disease determined from large MRI studies: A systematic review and meta-analysis.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: April 04, 2026

Trends and projections for Alzheimer's disease and other dementias in Kenya: Analysis of the global burden of disease data 1990-2021 in relation to Africa and the world.

Trends and projections for Alzheimer's disease and other dementias in Kenya: Analysis of the global burden of disease data 1990-2021 in relation to Africa and the world.

Journal: Journal of Alzheimer's disease : JAD

Published: March 30, 2026

Recruiting and retaining persons with suspected Alzheimer's disease and related dementias for genetic studies in selected African countries: Lived realities of researchers.

Recruiting and retaining persons with suspected Alzheimer's disease and related dementias for genetic studies in selected African countries: Lived realities of researchers.

Journal: Journal of Alzheimer's disease : JAD

Published: February 09, 2026

Plasma proteomic profiles of Alzheimer's disease and neurodegeneration in African cohorts.

Plasma proteomic profiles of Alzheimer's disease and neurodegeneration in African cohorts.

Journal: Nature communications

Published: December 05, 2025

Blood-based Biomarkers of Alzheimer's Disease and Neurodegeneration in an Indigenous African Cohort using both SIMOA and NULISA Platforms.

Blood-based Biomarkers of Alzheimer's Disease and Neurodegeneration in an Indigenous African Cohort using both SIMOA and NULISA Platforms.

Journal: Research square

Published: November 24, 2025

Blood-based biomarkers of Alzheimer's disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms.

Blood-based biomarkers of Alzheimer's disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms.

Journal: NPJ dementia

Published: September 23, 2025

Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers.

Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers.

Journal: Journal of the American College of Cardiology

Published: May 12, 2025

ABCA7 deletion lowers age at onset of Alzheimer's disease and interacts with APOE ε4 synergistically in African-ancestry populations.

ABCA7 deletion lowers age at onset of Alzheimer's disease and interacts with APOE ε4 synergistically in African-ancestry populations.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 28, 2025

Long term outcomes among African stroke survivors: 4 years follow up data from the CogFAST-Nigeria Study.

Long term outcomes among African stroke survivors: 4 years follow up data from the CogFAST-Nigeria Study.

Journal: Frontiers in stroke

Published: March 04, 2025

Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP): A global effort to identify genetic factors in Alzheimer's disease.

Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP): A global effort to identify genetic factors in Alzheimer's disease.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: February 05, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026